首頁 > 市場調查報告書 > 製藥

孤兒藥

市場調查報告書

商品編碼

2050978

鐮狀細胞疾病治療市場：依治療方法、年齡層、給藥途徑、最終用戶、通路和地區分類

Sickle Cell Disease Treatment Market, By Treatment Type, By Age Group, By Route of Administration, By End User, By Distribution Channel, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年鐮狀細胞疾病治療市場規模估計為37億美元，預計2033年將達到103.5億美元。預計從2026年到2033年，該市場將以15.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	37億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	15.80%	2033年市場規模預測：	103.5億美元

鐮狀細胞疾病（鐮狀細胞貧血症）是一種遺傳性血液疾病，會導致紅血球異常。這種疾病會影響人體組織和器官的氧氣供應。鐮狀細胞疾病在全球廣泛流行，尤其在撒哈拉以南非洲、中東、印度半島、地中海地區和南美洲更為常見。隨著診斷和檢測率的提高，以及人們對先進治療方法方案認知的不斷加深，預計未來幾年市場將呈現顯著的成長機會。新藥療法和基因治療方法的研發也在推動市場擴張。

市場動態

針對新藥研發和未來在研候選藥物的研究活動不斷增加，是全球鐮狀細胞疾病治療市場的主要成長要素。新興市場醫療保健支出不斷成長以及有利的報銷政策進一步推動了市場成長。骨髓移植等根治性治療方法的日益普及也是市場成長的驅動力。然而，先進治療方法的高昂費用以及發展中地區對該疾病認知度較低，限制了市場成長。基因治療方法的日益普及為市場相關人員帶來了巨大的機會。價格合理的再生醫學療法的開發也有望在不久的將來開闢新的發展道路。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球鐮狀細胞疾病治療市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球鐮狀細胞疾病治療市場報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過分析全球鐮狀細胞疾病治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Novartis AG
Emmaus Medical Inc.
Agios Pharmaceuticals Inc.
Bluebird Bio
Pfizer Inc.
Bristol-Myers Squibb Company
Celgene Corporation
GSK（GlaxoSmithKline）
Sanofi SA
Merck & Co., Inc.
Amgen Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Chugai Pharmaceutical Co., Ltd.
Daiichi Sankyo Company, Limited

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI7698

Sickle Cell Disease Treatment Market is estimated to be valued at USD 3.70 Bn in 2026 and is expected to reach USD 10.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.70 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	15.80%	2033 Value Projection:	USD 10.35 Bn

Sickle cell disease is a genetic blood disorder causing abnormal red blood cells. It affects the oxygen supply to tissues and organs in the body. This disorder is prevalent across worldwide, especially in Sub-Saharan Africa, the Middle East, Indian subcontinent, Mediterranean regions, and South and Central America. With growing diagnostic and detection rates, coupled with rising awareness regarding availability of advanced treatment options, the market is projected to showcase lucrative opportunities over the coming years. The development of new drug therapies and gene-therapy based treatment approaches are also fueling the market expansion.

Market Dynamics

Increasing research activities focusing on developing novel drugs and upcoming pipeline candidates are acting as a key growth driver for global sickle cell disease treatment market. Rising healthcare expenditures in emerging nations and favorable reimbursement policies are further supporting the market growth. Growing adoption of curative therapies such as bone marrow transplantation is also boosting the market. However, high costs associated with advanced treatment approaches and lack of awareness in underdeveloped regions are restraining the market growth. Rising adoption of gene-therapy based treatments presents significant opportunities for market players. Development of affordable regenerative treatment options also holds potential to create new avenues in the near future.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sickle cell disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Emmaus Medical Inc., Agios Pharmaceuticals Inc., Bluebird Bio, Pfizer Inc., Bristol-Myers Squibb Company, Celgene Corporation, GSK (GlaxoSmithKline), Sanofi S.A., Merck & Co., Inc., Amgen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co., Ltd., and Daiichi Sankyo Company, Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sickle cell disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell disease treatment market

Market Segmentation

By Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
Blood Transfusion
Bone Marrow Transplant
Pharmacotherapy
- Hydroxyurea Therapy
- Oxbryta
- Adakveo
- Pain Management Drugs
- Others
By Age Group Insights (Revenue, USD Bn, 2021 - 2033)
Adults
Pediatric
Geriatric
By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
Oral
Parenteral
By End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Specialty Clinics
Homecare Settings
Others
By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Novartis AG
Emmaus Medical Inc.
Agios Pharmaceuticals Inc.
Bluebird Bio
Pfizer Inc.
Bristol-Myers Squibb Company
Celgene Corporation
GSK (GlaxoSmithKline)
Sanofi S.A.
Merck & Co., Inc.
Amgen Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Chugai Pharmaceutical Co., Ltd.
Daiichi Sankyo Company, Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Sickle Cell Disease Treatment Market, By Treatment Type
- Global Sickle Cell Disease Treatment Market, By Age Group
- Global Sickle Cell Disease Treatment Market, By Route of Administration
- Global Sickle Cell Disease Treatment Market, By End User
- Global Sickle Cell Disease Treatment Market, By Distribution Channel
- Global Sickle Cell Disease Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Sickle Cell Disease Treatment Market, By Treatment Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Blood Transfusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Bone Marrow Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Pharmacotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
  - Hydroxyurea Therapy
  - Oxbryta
  - Adakveo
  - Pain Management Drugs
  - Others

5. Global Sickle Cell Disease Treatment Market, By Age Group, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)

6. Global Sickle Cell Disease Treatment Market, By Route of Administration, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)

7. Global Sickle Cell Disease Treatment Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)

8. Global Sickle Cell Disease Treatment Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)

9. Global Sickle Cell Disease Treatment Market, By Region, 2021 - 2033, Value (USD Billion)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Billion)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Billion)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emmaus Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agios Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bluebird Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chugai Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Daiichi Sankyo Company, Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies